"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
Nystatin topical preparations are contraindicated in patients with a history of hypersensitivity to any of their components.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/25/2010
Additional Nystatin Cream Information
Report Problems to the Food and Drug Administration
Find out what women really need.